| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 4 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | Australia | 3 | |
| #4 | Canada | 3 | |
| #5 | Republic of Korea | 3 | |
| #6 | Mexico | 3 | |
| #7 | United States | 3 | |
| #8 | WIPO (World Intellectual Property Organization) | 3 | |
| #9 | Hong Kong | 2 | |
| #10 | Singapore | 2 | |
| #11 | Israel | 1 | |
| #12 | India | 1 | |
| #13 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Microorganisms | |
| #4 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wiegand Marian | 28 |
| #2 | Kaufmann Christine | 16 |
| #3 | Marian Wiegand | 4 |
| #4 | Christine Kaufmann | 2 |
| #5 | Wiegand Marian Dr | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CN105473724A | Semi-live respiratory syncytial virus vaccine | |
| AU2014280545A1 | Semi-live respiratory syncytial virus vaccine | |
| EP2669381A1 | Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein |